These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9120466)

  • 21. A case of septal panniculitis secondary to interferon treatment.
    Ozuguz P; Kacar SD; Karaca S; Tokyol C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):351-2. PubMed ID: 24641120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin necrosis with subsequent formation of squamous cell carcinoma after subcutaneous interferon beta injection.
    Fruland JE; Sandermann S; Snow SN; Friedl A; Sharata HH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):488-9. PubMed ID: 9308568
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection].
    Ziegler VR; Kränke B; Soyer P; Aberer W
    Hautarzt; 1998 Apr; 49(4):310-2. PubMed ID: 9606633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.
    Zwibel HL;
    Acta Neurol Scand; 2006 Jun; 113(6):378-86. PubMed ID: 16674604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arthritis during interferon beta-1b treatment in multiple sclerosis.
    Altintas A; Alici Y; Melikoğlu M; Siva A
    Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous mucinoses complicating interferon beta-1b therapy.
    Benito-León J; Borbujo J; Cortés L
    Eur Neurol; 2002; 47(2):123-4. PubMed ID: 11844903
    [No Abstract]   [Full Text] [Related]  

  • 27. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis.
    Kumasaka R; Nakamura N; Shirato K; Fujita T; Murakami R; Shimada M; Nakamura M; Osawa H; Yamabe H; Okumura K
    Clin Exp Nephrol; 2006 Sep; 10(3):222-5. PubMed ID: 17009081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon beta-1b injection site reactions and necroses.
    Gaines AR; Varricchio F
    Mult Scler; 1998 Apr; 4(2):70-3. PubMed ID: 9599336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Subacute cutaneous lupus erythematosus and interferon beta-1 a].
    Schmutz J; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Feb; 127(2):237. PubMed ID: 10739993
    [No Abstract]   [Full Text] [Related]  

  • 32. Lupus erythematosus profundus (lupus panniculitis) induced by interferon-beta in a multiple sclerosis patient.
    Gono T; Matsuda M; Shimojima Y; Kaneko K; Murata H; Ikeda S
    J Clin Neurosci; 2007 Oct; 14(10):997-1000. PubMed ID: 17669654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-beta1b in multiple sclerosis.
    Buttmann M; Rieckmann P
    Expert Rev Neurother; 2007 Mar; 7(3):227-39. PubMed ID: 17341170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy.
    Sandberg-Wollheim M; Alteri E; Moraga MS; Kornmann G
    Mult Scler; 2011 Apr; 17(4):423-30. PubMed ID: 21220368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b.
    Laske C; Oschmann P; Tofighi J; Kühne BS; Diehl H; Bregenzer T; Kraus J; Chatzimanolis N; Bauer R; Traupe H; Kaps M
    Eur Neurol; 2001; 46(4):210-4. PubMed ID: 11721129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
    Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
    Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization in interferon-beta1a allergy: a case report.
    Fusun Kalpaklioglu A; Baccioglu Kavut A; Erdemoglu AK
    Int Arch Allergy Immunol; 2009; 149(2):178-80. PubMed ID: 19127077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
    Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
    Mazzon E; Guarneri C; Giacoppo S; Rifici C; Tchernev G; Polimeni G; Wollina U
    Int J Immunopathol Pharmacol; 2014; 27(4):669-74. PubMed ID: 25572749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.